Stock Rating Downgrade
The Value Trend Rating for Integra LifeSciences Holdings Co (NASDAQ: IART) weakened recently from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our next report.
Recent Price Action
Integra LifeSciences Holdings Co (NASDAQ: IART) stock enjoyed a large increase of 3.7% on 1/17/25. The stock closed at $24.10. Moreover, this advance was accompanied by above average trading volume at 121% of normal. Relative to the market the stock has been weak over the last nine months but has risen 8.3% during the last week.
Current PriceTarget Research Rating
Integra LifeSciences Holdings has a current Value Trend Rating of D (Negative). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Integra LifeSciences Holdings has a good Appreciation Score of 73 but a very low Power Rating of 13, triggering the Negative Value Trend Rating.
Be the first to comment